{"ticker": {"uuid": "90672735-564c-43a0-870f-861a382d1092", "symbol": "CALC", "name": "CalciMedica, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-16T05:52:27+00:00", "published_display": "16 Jul 2026 05:52", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) plans reverse split and warrant votes", "summary": "CalciMedica (NASDAQ: CALC) is holding a virtual annual stockholder meeting on August 19, 2026, to vote on eight proposals. Key agenda items include electing directors, ratifying auditors, amending the 2023 Equity Incentive Plan, and advisory votes on executive compensation. Most ", "url": "https://www.stocktitan.net/sec-filings/CALC/pre-14a-calci-medica-inc-preliminary-proxy-statement-e978df19ef34.html", "source_name": "Stock Titan", "published_at": "2026-07-13T21:11:15", "published_display": "13 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPV1hqSFhQM3VfYlNsdldfeVQ1dEdNNzI3S1RTaFJNSThrOXlPSWpMTlR5WWVxNnNsTzhTVGVvTE94R18wa1A0OUdFczBlcTIzeUFBZUt6VVJJMjNqNks3dmRUSzB4cE40anpNekJwUXAwcTFEcVh4QVZCYURXY2w4b2thdk5KZ3ZJMnI1REJObXo5UDdISXVCU1Z2ZVZoVmJpbnEzaDVWVmpGQVNFZzRXYnp0SWRRWWZGSnZnWlJ4aEloNmJBNGRMVFRjb3ZRbmV3QXF5S0pvTV9xNnpaMWV1Z1ZtM3lPdV9RcEdURHlfZFphdjlicEJndW0ybHNBa205?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-13T03:32:00+00:00", "published_display": "13 Jul 2026 03:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "CalciMedica Stock Short Interest Rises to 33.91%", "summary": "This article reports a significant increase in short interest for CalciMedica (NASDAQ:CALC) stock, which rose to 33.91% of its float as of June 15th. This represents a substantial increase from the previous reporting period, indicating growing bearish sentiment among investors. T", "url": "https://www.moomoo.com/news/post/72808056/calcimedica-stock-short-interest-rises-to-33-91", "source_name": "Moomoo", "published_at": "2026-07-11T14:11:40", "published_display": "11 Jul 2026 14:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) gains 17.1% shareholder as Alafi Capital ups stake in $2.8M deal", "summary": "Alafi Capital Company LLC and Christopher D. Alafi have increased their beneficial ownership in CalciMedica, Inc. (CALC) to 17.1%, now holding 5,242,996 shares. This includes a recent acquisition of 3,529,192 units in a private placement for approximately $2.8 million, along with", "url": "https://www.stocktitan.net/sec-filings/CALC/schedule-13d-calci-medica-inc-major-shareholder-acquisition-5-0d372258c1b0.html", "source_name": "Stock Titan", "published_at": "2026-07-11T01:09:24", "published_display": "11 Jul 2026 01:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CALC News | CALCIMEDICA INC (NASDAQ:CALC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE9PeDhXc3QwYkp4eW8wTHIxOGdOTWE5elk3bUN3MUVqNFB3UnNhQ2pkTzBkY1k1UTBCQXF3QnJvS21nQUpWdDZWM0lCc285NzN3SV9pNFkycE9GclU?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T00:00:02+00:00", "published_display": "11 Jul 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 3] CalciMedica, Inc. Initial Statement of Beneficial Ownership", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPVV94X0N1RmZhc2Q5Wm11dkgwRXp5UG1OaXMzT2QySHFfS1MwMElXMFdjMk1QVTRYZlBvMUhmbVpPRVMyYXIwRjBDV1pUNjJ3Y3JPd1VabTM3WE83a1JmYlpTc21oaHBjRllGWFlsbUMzWnpSdHZYTzIwNzZXRElvdGhzZXFDWXZvZFlBR2M0S1VvWThoRUxPaFY1NWlWVWRwUVlCUVhoNGU4aTdZc1RSZldKbUVVVjc1THFWMjVfc2YxTEd5Nnc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T21:36:54+00:00", "published_display": "10 Jul 2026 21:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alafi Capital Discloses Investment at CalciMedica with 17.1% Stake", "summary": "Alafi Capital Company LLC has disclosed a 17.1% stake in CalciMedica, Inc. common stock, filing a Schedule 13D on July 10, 2026. This investment includes shares from a June 2026 private placement and earlier open-market purchases, alongside warrants. Alafi Capital, an Emeryville-", "url": "https://www.tradingview.com/news/tradingview:b46374b1a43ac:0-alafi-capital-discloses-investment-at-calcimedica-with-17-1-stake/", "source_name": "TradingView", "published_at": "2026-07-10T21:09:24", "published_display": "10 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica, Inc. Announces Board Changes, Effective July 2, 2026", "summary": "CalciMedica, Inc. announced board changes effective July 2, 2026. The board increased its size from seven to eight directors, appointing Evgeny Zaytsev, M.D., Ph.D., as a Class I director. Additionally, Fred Middleton will retire from the board at the 2026 annual meeting of stock", "url": "https://www.marketscreener.com/news/calcimedica-inc-announces-board-changes-effective-july-2-2026-ce7f5ed8de8af225?utm_source=copy&utm_medium=social&utm_campaign=share", "source_name": "www.marketscreener.com", "published_at": "2026-07-08T13:10:44", "published_display": "08 Jul 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) director lists 2.1M shares and capped warrant holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOVExkTl9YMS03RVNSMVF6VHFZVlJqSDI3NTZYdElNU0loa2dmdi1RSUhnY1VtNTFLRnFpenRwb0NKdVVtZjZwcVZaaVdVcVJHQVVpb1BuS19vbGF1SUZXTUI4TW9GR0N6enMwNl9zVVEzSkFtemdza1dTVWFFU0IyZ1NaclZNRFVOQnRfZThKX0ZreDZtcVBxdUlNdVJYLVRNSmxFYUNMSVJrZU5QZU5ZWWFvc1lFWW5sWGhRVGx6QVQ4cWdiTEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T20:59:57+00:00", "published_display": "07 Jul 2026 20:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) appoints Dr. Evgeny Zaytsev to board", "summary": "CalciMedica, Inc. (NASDAQ: CALC) has appointed Dr. Evgeny Zaytsev to its board of directors as a Class I director, effective July 2, 2026. This increases the board size from seven to eight, though it will return to seven upon Fred Middleton's retirement at the 2026 annual meeting", "url": "https://www.stocktitan.net/sec-filings/CALC/8-k-calci-medica-inc-reports-material-event-670359b1745d.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:39:35", "published_display": "07 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at CalciMedica (CALC) granted stock options on 20,000 shares", "summary": "CalciMedica, Inc. director Evgeny Zaytsev was granted stock options for 20,000 shares of common stock, with an exercise price of $0.9654 per share and an expiration date of July 1, 2036. These options will vest in equal monthly installments over three years. This award is compens", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-d9e1628b4818.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:39:35", "published_display": "07 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T15:08:06+00:00", "published_display": "04 Jul 2026 15:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CALC - CalciMedica Inc Options", "summary": "This article provides a detailed financial overview of CalciMedica Inc. (CALC), including its recent stock performance, key financial metrics, insider and institutional ownership, and analyst recommendations. The data presented covers market capitalization, sales, earnings per sh", "url": "https://finviz.com/stock?t=CALC&ty=oc&p=d&r=ytd&ov=plot", "source_name": "Finviz", "published_at": "2026-07-03T16:09:50", "published_display": "03 Jul 2026 16:09", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bering Partners II Discloses Investment at CalciMedica with 6.9% Stake", "summary": "Bering Partners II, L.P. has disclosed a 6.9% stake in CalciMedica, Inc., acquiring 1,450,267 units in a private placement and shifting its prior 13G filing to a 13D. The fund also increased its warrant ownership cap to 19.99%, indicating potential for further action. Bering Part", "url": "https://www.tradingview.com/news/tradingview:2a7a6eea0c50a:0-bering-partners-ii-discloses-investment-at-calcimedica-with-6-9-stake/", "source_name": "TradingView", "published_at": "2026-07-03T00:40:00", "published_display": "03 Jul 2026 00:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) gains 6.9% holder via June 2026 private placement", "summary": "Bering Partners II and its affiliates have disclosed a 6.9% beneficial ownership stake in CalciMedica (NASDAQ: CALC), totaling 2,113,513 common shares. This significant position was accumulated through a series of transactions, including the company's merger with Graybug Vision, ", "url": "https://www.stocktitan.net/sec-filings/CALC/schedule-13d-calci-medica-inc-major-shareholder-acquisition-5-2f51901d9227.html", "source_name": "Stock Titan", "published_at": "2026-07-03T00:40:00", "published_display": "03 Jul 2026 00:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) insiders add shares via open-market and unit purchases", "summary": "CalciMedica insiders Eric Roberts and A. Rachel Leheny have increased their stakes in the company through open-market purchases and a public offering. Roberts now beneficially owns 6.4% and Leheny 6.3% of CalciMedica's common stock, based on 30,736,401 shares outstanding as of Ju", "url": "https://www.stocktitan.net/sec-filings/CALC/schedule-13d-a-calci-medica-inc-amended-major-shareholder-report-36ae9656e02b.html", "source_name": "Stock Titan", "published_at": "2026-07-01T09:40:58", "published_display": "01 Jul 2026 09:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 CalciMedica Inc For: 29 June By Investing.com", "summary": "This article from Investing.com announces the filing of a Form 4 for CalciMedica Inc. on June 29. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the ownership of company stock by an insider. The artic", "url": "https://ng.investing.com/news/stock-market-news/form-4-calcimedica-inc-for-29-june-93CH-2578159", "source_name": "Investing.com Nigeria", "published_at": "2026-06-30T10:10:11", "published_display": "30 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) Chief Medical Officer acquires 124,486 shares via board-approved deal", "summary": "CalciMedica's Chief Medical Officer, Sudarshan Hebbar, acquired 124,486 shares of common stock at an indicated price of $0.8033 per share on June 25, 2026, bringing his total direct holdings to 186,025 shares. This transaction was part of a Securities Purchase Agreement dated Jun", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-e435b15c22e2.html", "source_name": "Stock Titan", "published_at": "2026-06-29T22:39:14", "published_display": "29 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) insider-affiliated fund buys 248,972 new shares at $0.8033", "summary": "An investment fund associated with CalciMedica director Fred A. Middleton purchased 248,972 shares of common stock at $0.8033 per share directly from the company. This transaction, approved by an independent board committee, increased the fund's total holdings to 1,063,272 shares", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-76f97188e2ab.html", "source_name": "Stock Titan", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Robert N. Wilson adds 1.18M CalciMedica (CALC) shares via purchase deal", "summary": "CalciMedica director Robert N. Wilson acquired 1,182,621 shares of Common Stock at $0.8033 per share through a Securities Purchase Agreement. This transaction, which closed on June 25, 2026, and was approved by an independent board committee, increased his direct holdings to 1,60", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-6cc9a8bad3ee.html", "source_name": "Stock Titan", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calcimedica director Fred Middleton acquires $199,999 in stock.", "summary": "CalciMedica director Fred Middleton recently acquired 248,972 shares of the company's common stock for approximately $199,999, at a price of $0.8033 per share. This acquisition was made through Sanderling Venture Partners VI Co-Investment Fund, L.P., and adds to Middleton's signi", "url": "https://www.investing.com/news/insider-trading-news/calcimedica-director-fred-middleton-acquires-199999-in-stock-93CH-4765450", "source_name": "Investing.com", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] CalciMedica, Inc. Insider Trading Activity", "summary": "CalciMedica, Inc.'s director, CEO, and 10% owner, Rachel A. Leheny, acquired 186,729 shares of common stock at $0.8033 per share through a Securities Purchase Agreement. This transaction, which closed on June 25, 2026, increased her direct holdings to 317,655 shares. The purchase", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-ad9ec31c8e8b.html", "source_name": "Stock Titan", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) chief business officer gets 186,729-share stock award at $0.8033", "summary": "CalciMedica's chief business officer, Eric W. Roberts, was granted 186,729 shares of common stock at a price of $0.8033 per share. This stock award was part of a Securities Purchase Agreement approved by an independent committee of the board of directors. Following this transacti", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-bb8b4e85b488.html", "source_name": "Stock Titan", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Stock Purchases: June 29, 2026 | PBLS Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOYzVmX0h1OEhfQ1hmSC1ncThJMm1WSzE1alJQRDV3cmhsNDh4aHFHeDJjUEd3WjVid05qeW5sYVdrWmhEb2RoOTdtNVA4bktxb0ZmOHpPS08xR201ek80Z214Rmdhbk4zOWtnbGdGcTJTbUdhLTBMeGhjcF9iMTd4Xw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) lenders capped at 4.99% ownership after loan amendment", "summary": "CalciMedica's lenders are capped at 4.99% ownership due to an amendment to their loan documents, preventing conversion of loans into common stock beyond this threshold. The amendment, effective June 23, 2026, details that lenders can convert up to $3 million of outstanding princi", "url": "https://www.stocktitan.net/sec-filings/CALC/schedule-13g-a-calci-medica-inc-amended-passive-investment-disclosure-1787d16d6e39.html", "source_name": "Stock Titan", "published_at": "2026-06-25T21:12:11", "published_display": "25 Jun 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (Nasdaq: CALC) raises $15M, maps PAH and PH trial plans", "summary": "CalciMedica (Nasdaq: CALC) has raised approximately $15 million in upfront gross proceeds, with potential for up to $49 million through warrant exercises, from a private placement to advance its pulmonary hypertension (PH) program. The company plans to use these funds for a Phase", "url": "https://www.stocktitan.net/sec-filings/CALC/8-k-calci-medica-inc-reports-material-event-88ef397841e3.html", "source_name": "Stock Titan", "published_at": "2026-06-24T21:09:42", "published_display": "24 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) extends Avenue loan and issues new $1.00 warrants", "summary": "CalciMedica (NASDAQ: CALC) has amended its loan and warrant agreements with Avenue funds, extending the maturity of its $10 million loan to September 1, 2029, and the interest-only period to September 30, 2027. In exchange, the company agreed to a $200,000 increase in the final p", "url": "https://www.stocktitan.net/sec-filings/CALC/8-k-calci-medica-inc-reports-material-event-5fdcffe0f810.html", "source_name": "Stock Titan", "published_at": "2026-06-24T20:11:00", "published_display": "24 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQM0ExNm9zZVBVMzB2cTFsYkhQeDJyeUV5Y1lSdWdsa2V2STFTSFBkYVlrRDJaUmE0bjZVLUxmZEh1UkFPbndtdWVDWmJBcEJaSmpTSlN4RkFkdF9EYkhFUXh3YWxqREkxRllfRXE0bFVuSkMwaExFNmk0UmNoa2R2NmQyb0p1N2pudENMMGMwWmVGT0J5SUxfeE5hT2hpUms1NHR4NzY1VWpNQVFYUWJkUnN3?oc=5", "source_name": "TradingView", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQcjZqdzdBcURDdWxCZUtoU1dTaHYtVUFRdlo1a3ZGZGY3a1dBX2x2UVE3Y1hoX1duLXhGU2p0UXU2eTctNng5eFJ5c1M0bHBNQ0VmZTFZanhYU21yTVo0UTQtVENveVV1aWdpc3luUlgza3AyUEI2OGx4aEhXc0pBTHpWUThSYXI1S3RTS21lQ21vWjd6MGY4ZDRwVWlEakc3SmFKN09aM0Rlb2pFT3BNNW1GTExnSElFb2NqR3JhX0J3MlptQy1mMk9IOTZtdS1HU25fLU9aOU9XZi1PRDlkZVI2cnhackHSAewBQVVfeXFMTlc2N3pIUkxDd1NtTlVRMEdac1JNSDF3cUNidkZrTElQREZaUTZjZmFHdUVWYW8wcDg1LThGbnlPb0VQUFI4ZXdjSXR6Ym5DREM1X2lyQUtYTzF3XzBBTGRGcEZQQ3FjLWxCQ0locVM2dGZJR1kxYmlBQXdsbFhfbFFISS1wSUkxQmp4U2d2Z3JHbXRPMUpnajBydTRmNnQzZmF5eEdzOVFRNUdDNVV0aDJQNERCaXN3ZGo1UUc1ZGkwOFYzcDgxS1ltZllDeTFxNFIxT3FyOUxLMFNrLUhtOFNFV0xMYkM5TlpWMzk?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CALC Stock Slumped 76% On Wednesday \u2014 Here\u2019s Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNTE9mX1c4U1NjWWhXVHY2WjdPUXc3aTFJWFJHUVZDS2tucFQ4aWphMHJqWmlwWmVUTjNQTVB2QmdnX0R5bnVXdU1tSHNLa24xQmRCN041QTdOUl83UnlSMTBwREJoREUwYjJvdFVRa0ZPeFZLVFEwLU04NFFraGZwY2NDX2tuU3BVZzJpTEpHX3dVTkhyNlpnNVVUTGJiSnJvaVpMU0k4ano?oc=5", "source_name": "Stocktwits", "published_at": "2026-01-28T22:56:03+00:00", "published_display": "28 Jan 2026 22:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-16T05:52:27+00:00", "published_display": "16 Jul 2026 05:52", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) plans reverse split and warrant votes", "summary": "CalciMedica (NASDAQ: CALC) is holding a virtual annual stockholder meeting on August 19, 2026, to vote on eight proposals. Key agenda items include electing directors, ratifying auditors, amending the 2023 Equity Incentive Plan, and advisory votes on executive compensation. Most ", "url": "https://www.stocktitan.net/sec-filings/CALC/pre-14a-calci-medica-inc-preliminary-proxy-statement-e978df19ef34.html", "source_name": "Stock Titan", "published_at": "2026-07-13T21:11:15", "published_display": "13 Jul 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Teleflex Incorporated (TFX) Stock Analysis: Unpacking a 32.3% Revenue Growth in the Healthcare Sector", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPQ3B5MlVsTlBhcXdmUVllazV2SWFHTmRudHVNdFY3RUYtR1FTXzNIV1VYODF0bTMyVThkOE1LZC11TGN2dUxBZzRPTDQxUDVDdF9PWW5VUk1rZVJkdXRjbTQ2MU1wa3BtejZ5NUhWY1dQLUZLS3duak1fMzIxcnNwUmc4X3N5Q1JXMFNQY1J0ZVd5aHF4NHVUQkpnNlNUU1VWcVljNjhGbkFicUNyOXktR0lZWkVxT09oU0VQZnZObG5RMkJDWHh4czRrUktNZFNrZVhKWnF1YTZ2ZmVzTG14WG1n?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:17+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica Stock Short Interest Rises to 33.91%", "summary": "This article reports a significant increase in short interest for CalciMedica (NASDAQ:CALC) stock, which rose to 33.91% of its float as of June 15th. This represents a substantial increase from the previous reporting period, indicating growing bearish sentiment among investors. T", "url": "https://www.moomoo.com/news/post/72808056/calcimedica-stock-short-interest-rises-to-33-91", "source_name": "Moomoo", "published_at": "2026-07-11T14:11:40", "published_display": "11 Jul 2026 14:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) gains 17.1% shareholder as Alafi Capital ups stake in $2.8M deal", "summary": "Alafi Capital Company LLC and Christopher D. Alafi have increased their beneficial ownership in CalciMedica, Inc. (CALC) to 17.1%, now holding 5,242,996 shares. This includes a recent acquisition of 3,529,192 units in a private placement for approximately $2.8 million, along with", "url": "https://www.stocktitan.net/sec-filings/CALC/schedule-13d-calci-medica-inc-major-shareholder-acquisition-5-0d372258c1b0.html", "source_name": "Stock Titan", "published_at": "2026-07-11T01:09:24", "published_display": "11 Jul 2026 01:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 93, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CALC News | CALCIMEDICA INC (NASDAQ:CALC)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE9PeDhXc3QwYkp4eW8wTHIxOGdOTWE5elk3bUN3MUVqNFB3UnNhQ2pkTzBkY1k1UTBCQXF3QnJvS21nQUpWdDZWM0lCc285NzN3SV9pNFkycE9GclU?oc=5", "source_name": "ChartMill", "published_at": "2026-07-11T00:00:02+00:00", "published_display": "11 Jul 2026 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 3] CalciMedica, Inc. Initial Statement of Beneficial Ownership", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPVV94X0N1RmZhc2Q5Wm11dkgwRXp5UG1OaXMzT2QySHFfS1MwMElXMFdjMk1QVTRYZlBvMUhmbVpPRVMyYXIwRjBDV1pUNjJ3Y3JPd1VabTM3WE83a1JmYlpTc21oaHBjRllGWFlsbUMzWnpSdHZYTzIwNzZXRElvdGhzZXFDWXZvZFlBR2M0S1VvWThoRUxPaFY1NWlWVWRwUVlCUVhoNGU4aTdZc1RSZldKbUVVVjc1THFWMjVfc2YxTEd5Nnc?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T21:36:54+00:00", "published_display": "10 Jul 2026 21:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Alafi Capital Discloses Investment at CalciMedica with 17.1% Stake", "summary": "Alafi Capital Company LLC has disclosed a 17.1% stake in CalciMedica, Inc. common stock, filing a Schedule 13D on July 10, 2026. This investment includes shares from a June 2026 private placement and earlier open-market purchases, alongside warrants. Alafi Capital, an Emeryville-", "url": "https://www.tradingview.com/news/tradingview:b46374b1a43ac:0-alafi-capital-discloses-investment-at-calcimedica-with-17-1-stake/", "source_name": "TradingView", "published_at": "2026-07-10T21:09:24", "published_display": "10 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica, Inc. Announces Board Changes, Effective July 2, 2026", "summary": "CalciMedica, Inc. announced board changes effective July 2, 2026. The board increased its size from seven to eight directors, appointing Evgeny Zaytsev, M.D., Ph.D., as a Class I director. Additionally, Fred Middleton will retire from the board at the 2026 annual meeting of stock", "url": "https://www.marketscreener.com/news/calcimedica-inc-announces-board-changes-effective-july-2-2026-ce7f5ed8de8af225?utm_source=copy&utm_medium=social&utm_campaign=share", "source_name": "www.marketscreener.com", "published_at": "2026-07-08T13:10:44", "published_display": "08 Jul 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) director lists 2.1M shares and capped warrant holdings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxOVExkTl9YMS03RVNSMVF6VHFZVlJqSDI3NTZYdElNU0loa2dmdi1RSUhnY1VtNTFLRnFpenRwb0NKdVVtZjZwcVZaaVdVcVJHQVVpb1BuS19vbGF1SUZXTUI4TW9GR0N6enMwNl9zVVEzSkFtemdza1dTVWFFU0IyZ1NaclZNRFVOQnRfZThKX0ZreDZtcVBxdUlNdVJYLVRNSmxFYUNMSVJrZU5QZU5ZWWFvc1lFWW5sWGhRVGx6QVQ4cWdiTEE?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T20:59:57+00:00", "published_display": "07 Jul 2026 20:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) appoints Dr. Evgeny Zaytsev to board", "summary": "CalciMedica, Inc. (NASDAQ: CALC) has appointed Dr. Evgeny Zaytsev to its board of directors as a Class I director, effective July 2, 2026. This increases the board size from seven to eight, though it will return to seven upon Fred Middleton's retirement at the 2026 annual meeting", "url": "https://www.stocktitan.net/sec-filings/CALC/8-k-calci-medica-inc-reports-material-event-670359b1745d.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:39:35", "published_display": "07 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at CalciMedica (CALC) granted stock options on 20,000 shares", "summary": "CalciMedica, Inc. director Evgeny Zaytsev was granted stock options for 20,000 shares of common stock, with an exercise price of $0.9654 per share and an expiration date of July 1, 2036. These options will vest in equal monthly installments over three years. This award is compens", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-d9e1628b4818.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:39:35", "published_display": "07 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T15:08:06+00:00", "published_display": "04 Jul 2026 15:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CALC - CalciMedica Inc Options", "summary": "This article provides a detailed financial overview of CalciMedica Inc. (CALC), including its recent stock performance, key financial metrics, insider and institutional ownership, and analyst recommendations. The data presented covers market capitalization, sales, earnings per sh", "url": "https://finviz.com/stock?t=CALC&ty=oc&p=d&r=ytd&ov=plot", "source_name": "Finviz", "published_at": "2026-07-03T16:09:50", "published_display": "03 Jul 2026 16:09", "sentiment": "negative", "sentiment_pct": 33, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bering Partners II Discloses Investment at CalciMedica with 6.9% Stake", "summary": "Bering Partners II, L.P. has disclosed a 6.9% stake in CalciMedica, Inc., acquiring 1,450,267 units in a private placement and shifting its prior 13G filing to a 13D. The fund also increased its warrant ownership cap to 19.99%, indicating potential for further action. Bering Part", "url": "https://www.tradingview.com/news/tradingview:2a7a6eea0c50a:0-bering-partners-ii-discloses-investment-at-calcimedica-with-6-9-stake/", "source_name": "TradingView", "published_at": "2026-07-03T00:40:00", "published_display": "03 Jul 2026 00:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) gains 6.9% holder via June 2026 private placement", "summary": "Bering Partners II and its affiliates have disclosed a 6.9% beneficial ownership stake in CalciMedica (NASDAQ: CALC), totaling 2,113,513 common shares. This significant position was accumulated through a series of transactions, including the company's merger with Graybug Vision, ", "url": "https://www.stocktitan.net/sec-filings/CALC/schedule-13d-calci-medica-inc-major-shareholder-acquisition-5-2f51901d9227.html", "source_name": "Stock Titan", "published_at": "2026-07-03T00:40:00", "published_display": "03 Jul 2026 00:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) insiders add shares via open-market and unit purchases", "summary": "CalciMedica insiders Eric Roberts and A. Rachel Leheny have increased their stakes in the company through open-market purchases and a public offering. Roberts now beneficially owns 6.4% and Leheny 6.3% of CalciMedica's common stock, based on 30,736,401 shares outstanding as of Ju", "url": "https://www.stocktitan.net/sec-filings/CALC/schedule-13d-a-calci-medica-inc-amended-major-shareholder-report-36ae9656e02b.html", "source_name": "Stock Titan", "published_at": "2026-07-01T09:40:58", "published_display": "01 Jul 2026 09:40", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 CalciMedica Inc For: 29 June By Investing.com", "summary": "This article from Investing.com announces the filing of a Form 4 for CalciMedica Inc. on June 29. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the ownership of company stock by an insider. The artic", "url": "https://ng.investing.com/news/stock-market-news/form-4-calcimedica-inc-for-29-june-93CH-2578159", "source_name": "Investing.com Nigeria", "published_at": "2026-06-30T10:10:11", "published_display": "30 Jun 2026 10:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) Chief Medical Officer acquires 124,486 shares via board-approved deal", "summary": "CalciMedica's Chief Medical Officer, Sudarshan Hebbar, acquired 124,486 shares of common stock at an indicated price of $0.8033 per share on June 25, 2026, bringing his total direct holdings to 186,025 shares. This transaction was part of a Securities Purchase Agreement dated Jun", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-e435b15c22e2.html", "source_name": "Stock Titan", "published_at": "2026-06-29T22:39:14", "published_display": "29 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 67, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) insider-affiliated fund buys 248,972 new shares at $0.8033", "summary": "An investment fund associated with CalciMedica director Fred A. Middleton purchased 248,972 shares of common stock at $0.8033 per share directly from the company. This transaction, approved by an independent board committee, increased the fund's total holdings to 1,063,272 shares", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-76f97188e2ab.html", "source_name": "Stock Titan", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Robert N. Wilson adds 1.18M CalciMedica (CALC) shares via purchase deal", "summary": "CalciMedica director Robert N. Wilson acquired 1,182,621 shares of Common Stock at $0.8033 per share through a Securities Purchase Agreement. This transaction, which closed on June 25, 2026, and was approved by an independent board committee, increased his direct holdings to 1,60", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-6cc9a8bad3ee.html", "source_name": "Stock Titan", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Calcimedica director Fred Middleton acquires $199,999 in stock.", "summary": "CalciMedica director Fred Middleton recently acquired 248,972 shares of the company's common stock for approximately $199,999, at a price of $0.8033 per share. This acquisition was made through Sanderling Venture Partners VI Co-Investment Fund, L.P., and adds to Middleton's signi", "url": "https://www.investing.com/news/insider-trading-news/calcimedica-director-fred-middleton-acquires-199999-in-stock-93CH-4765450", "source_name": "Investing.com", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] CalciMedica, Inc. Insider Trading Activity", "summary": "CalciMedica, Inc.'s director, CEO, and 10% owner, Rachel A. Leheny, acquired 186,729 shares of common stock at $0.8033 per share through a Securities Purchase Agreement. This transaction, which closed on June 25, 2026, increased her direct holdings to 317,655 shares. The purchase", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-ad9ec31c8e8b.html", "source_name": "Stock Titan", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (CALC) chief business officer gets 186,729-share stock award at $0.8033", "summary": "CalciMedica's chief business officer, Eric W. Roberts, was granted 186,729 shares of common stock at a price of $0.8033 per share. This stock award was part of a Securities Purchase Agreement approved by an independent committee of the board of directors. Following this transacti", "url": "https://www.stocktitan.net/sec-filings/CALC/form-4-calci-medica-inc-insider-trading-activity-bb8b4e85b488.html", "source_name": "Stock Titan", "published_at": "2026-06-29T13:11:11", "published_display": "29 Jun 2026 13:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Stock Purchases: June 29, 2026 | PBLS Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOYzVmX0h1OEhfQ1hmSC1ncThJMm1WSzE1alJQRDV3cmhsNDh4aHFHeDJjUEd3WjVid05qeW5sYVdrWmhEb2RoOTdtNVA4bktxb0ZmOHpPS08xR201ek80Z214Rmdhbk4zOWtnbGdGcTJTbUdhLTBMeGhjcF9iMTd4Xw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) lenders capped at 4.99% ownership after loan amendment", "summary": "CalciMedica's lenders are capped at 4.99% ownership due to an amendment to their loan documents, preventing conversion of loans into common stock beyond this threshold. The amendment, effective June 23, 2026, details that lenders can convert up to $3 million of outstanding princi", "url": "https://www.stocktitan.net/sec-filings/CALC/schedule-13g-a-calci-medica-inc-amended-passive-investment-disclosure-1787d16d6e39.html", "source_name": "Stock Titan", "published_at": "2026-06-25T21:12:11", "published_display": "25 Jun 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (Nasdaq: CALC) raises $15M, maps PAH and PH trial plans", "summary": "CalciMedica (Nasdaq: CALC) has raised approximately $15 million in upfront gross proceeds, with potential for up to $49 million through warrant exercises, from a private placement to advance its pulmonary hypertension (PH) program. The company plans to use these funds for a Phase", "url": "https://www.stocktitan.net/sec-filings/CALC/8-k-calci-medica-inc-reports-material-event-88ef397841e3.html", "source_name": "Stock Titan", "published_at": "2026-06-24T21:09:42", "published_display": "24 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CalciMedica (NASDAQ: CALC) extends Avenue loan and issues new $1.00 warrants", "summary": "CalciMedica (NASDAQ: CALC) has amended its loan and warrant agreements with Avenue funds, extending the maturity of its $10 million loan to September 1, 2029, and the interest-only period to September 30, 2027. In exchange, the company agreed to a $200,000 increase in the final p", "url": "https://www.stocktitan.net/sec-filings/CALC/8-k-calci-medica-inc-reports-material-event-5fdcffe0f810.html", "source_name": "Stock Titan", "published_at": "2026-06-24T20:11:00", "published_display": "24 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQM0ExNm9zZVBVMzB2cTFsYkhQeDJyeUV5Y1lSdWdsa2V2STFTSFBkYVlrRDJaUmE0bjZVLUxmZEh1UkFPbndtdWVDWmJBcEJaSmpTSlN4RkFkdF9EYkhFUXh3YWxqREkxRllfRXE0bFVuSkMwaExFNmk0UmNoa2R2NmQyb0p1N2pudENMMGMwWmVGT0J5SUxfeE5hT2hpUms1NHR4NzY1VWpNQVFYUWJkUnN3?oc=5", "source_name": "TradingView", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PDS BIOTECHNOLOGY ($PDSB) Releases Q1 2026 Earnings | PDSB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOcEdqLWM1SmVuNHpvZ2poNU5mOFppaWNtUi1IQVRHTmgxLUpyZHdUSDRnekdzMmVFQzFzUGo2RjlYenpCaTlfcUZhMm1yTzRwWUxnM01WY0libmxIVXNSM3RtMGxMY2RURTdMVW96bGU0SGZXRkE2SnVQdVNNUWw5RWtJQVJMX2pQQnRBRHBKMlRCUDct?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxOWWM3V1pmZzdlY1llRTljQmNLQ2UwdDdQaFVEcng2WVdrNE9qNzRrNVpBVlJNMGltQUhBUG1qellCVHNiM09fUkFHRW1kMEpvazJoLU11N3c4YnlWUXpmVl82aWNKeTA4U1RwSHNNSVd4d0lwWHRJclQ2TGNHWUpBQTgzbTBMVk05VGxYN0RwcmpTYklOQUFSWDhsSHZlQVpndmlPRGNvTmRmeHNILWg4ZE5jMjRoN01XNENiaVU2UDUyOWJfYUZCTm5URmtwTHJsTjJYNHo3RkxsQjBSMnBmdVZVWkFwN2PSAewBQVVfeXFMT3htM016bEt0TTdyOXE2amppMGpubTNfOFU4cGpxd2dFZkJDTjR3c0ZqOHpHYWZoamNLdmkxVmNYNklxTEM4NTU0bDZwUTZ1SW5Jc1c4NmRJN3lKQUVqUUNYYWptd2ZYNE9TeEhMRzFvbEt0bjk1TVhyVG44UnJnNDllTlFsalJVUTZwcEEzWXljbzdaQXdWWDlHQW56bGxqeG90UlFmaFFLekJlUlNIOVE4SGNHcE9pOW1KSllleVdwNERiaVl2NmxtNTNyaUtnSFY1VHUzcDJsWE9xb3R1ajZ2RGhkXzJzTldMOVA?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxOUjRRb0hlcHlOazlmelFaVVJSQWNnRmExZVBEQW1HMmVLTjNyU3d4WElsU05hdGlfYWFSY0twMTNWOVVCY0h4U2dYQ19BQl9pa3o0NWNBLW50WmFsSEVHdmJFV3JabnN5MFZpUWZabjZzY2tjMUtxbndONm9DS3NxTUp3Qjg2dWZnMDR2NXZ2eU80MWhSODVKdVgxZVJ6TWs3RFpCaDFqMXVtVkhmRVlOcWtqYUV1X1FPcGpfdERhRmwzdkZDaWxtSnJnd25Oam4yTnFHTFBkZi0tM1BZdkE?oc=5", "source_name": "StockStory", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CALC Stock Slumped 76% On Wednesday \u2014 Here\u2019s Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNTE9mX1c4U1NjWWhXVHY2WjdPUXc3aTFJWFJHUVZDS2tucFQ4aWphMHJqWmlwWmVUTjNQTVB2QmdnX0R5bnVXdU1tSHNLa24xQmRCN041QTdOUl83UnlSMTBwREJoREUwYjJvdFVRa0ZPeFZLVFEwLU04NFFraGZwY2NDX2tuU3BVZzJpTEpHX3dVTkhyNlpnNVVUTGJiSnJvaVpMU0k4ano?oc=5", "source_name": "Stocktwits", "published_at": "2026-01-28T22:56:03+00:00", "published_display": "28 Jan 2026 22:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Stock Plummets 20% After Earnings. Why Soft Revenue Isn\u2019t the Only Problem.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxPMTdzUkZQWG9tTW9zT3FxSWtzdkdLLUNYVkRJMDh2X1VRSlVrdmVkS3FCSVFpX210VUxVSUF1Q2FYakw1ZUxyQlpoZHZpM1RYQzBOYlpEWENxeGM1bXBZNFYxQjZRcFBpcS0tVVhRdzFTejBrVzU3aU9QQXdnYkZBMWxB?oc=5", "source_name": "Barron's", "published_at": "2026-01-27T08:00:00+00:00", "published_display": "27 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPV1hqSFhQM3VfYlNsdldfeVQ1dEdNNzI3S1RTaFJNSThrOXlPSWpMTlR5WWVxNnNsTzhTVGVvTE94R18wa1A0OUdFczBlcTIzeUFBZUt6VVJJMjNqNks3dmRUSzB4cE40anpNekJwUXAwcTFEcVh4QVZCYURXY2w4b2thdk5KZ3ZJMnI1REJObXo5UDdISXVCU1Z2ZVZoVmJpbnEzaDVWVmpGQVNFZzRXYnp0SWRRWWZGSnZnWlJ4aEloNmJBNGRMVFRjb3ZRbmV3QXF5S0pvTV9xNnpaMWV1Z1ZtM3lPdV9RcEdURHlfZFphdjlicEJndW0ybHNBa205?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-07-13T03:32:00+00:00", "published_display": "13 Jul 2026 03:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 77, "total_relevant": 48, "sentiment_summary": {"positive": 16, "negative": 4, "neutral": 28, "score": 56, "total": 48, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 13.55, "count": 24}, {"event": "earnings", "label": "Earnings", "weight": 8.95, "count": 17}, {"event": "deals", "label": "Deals and strategy", "weight": 3.85, "count": 7}], "positive_events": 16, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 0.93, "latest_week": "2026-07-10", "one_week_move": -3.7, "four_week_move": 7.3, "twelve_week_move": 54.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.503732, "market_dynamics_buy_signal": false, "relative_strength": -67.227205, "fair_value_gap": -69.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 50.0348, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.7% over one week, +7.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 16}, {"label": "Market source", "count": 6}, {"label": "TradingView", "count": 4}, {"label": "Stocktwits", "count": 2}, {"label": "Quiver Quantitative", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Barron's", "count": 2}, {"label": "DirectorsTalk Interviews", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 40}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Earnings", "count": 17}, {"label": "Deals and strategy", "count": 7}]}, "insights": [{"label": "Weighted tone", "value": "56/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "40", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.7% over one week, +7.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?"}], "updated_at": "2026-07-17T10:33:47.830897+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}